These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21040783)

  • 1. Taking PAT to the next level.
    Ciurczak EW; Ketolainen J; Laitinen R; Aaltonen J; Lindén HH
    Eur J Pharm Sci; 2011 Jan; 42(1-2):1-2. PubMed ID: 21040783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
    Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
    Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT).
    de Matas M; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; Oostra W; Weimer M; Öhrngren P; Rantanen J
    Eur J Pharm Sci; 2016 Jul; 90():2-7. PubMed ID: 27112991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput process development for biopharmaceutical drug substances.
    Bhambure R; Kumar K; Rathore AS
    Trends Biotechnol; 2011 Mar; 29(3):127-35. PubMed ID: 21255855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.
    Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of future training needs for PhD graduates for European pharmaceutical companies: a report from the committee on industrial relations (CIR) of EUFEPS. European Federation for Pharmaceutical Sciences.
    Eur J Pharm Sci; 1999 Feb; 7(3):iii-v. PubMed ID: 10048939
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives of family medicine in Central and Eastern Europe.
    Seifert B; Svab I; Madis T; Kersnik J; Windak A; Steflova A; Byma S
    Fam Pract; 2008 Apr; 25(2):113-8. PubMed ID: 18304970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
    Yu LX; Akseli I; Allen B; Amidon G; Bizjak TG; Boam A; Caulk M; Doleski D; Famulare J; Fisher AC; Furness S; Hasselbalch B; Havel H; Hoag SW; Iser R; Johnson BD; Ju R; Katz P; Lacana E; Lee SL; Lostritto R; McNally G; Mehta M; Mohan G; Nasr M; Nosal R; Oates M; O'Connor T; Polli J; Raju GK; Ramanadham M; Randazzo G; Rosencrance S; Schwendeman A; Selen A; Seo P; Shah V; Sood R; Thien MP; Tong T; Trout BL; Tyner K; Vaithiyalingam S; VanTrieste M; Walsh F; Wesdyk R; Woodcock J; Wu G; Wu L; Yu L; Zezza D
    AAPS J; 2016 Mar; 18(2):528-43. PubMed ID: 26860627
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Objectives and organization of the International Conference on Harmonization].
    Juillet Y
    Ann Pharm Fr; 1999 Mar; 57(2):137-42. PubMed ID: 10365469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of the EMA Joint Regulators/Industry QbD workshop (London, UK; 28-29 January 2014).
    Cook G; France G; Holte Ø; Lorenti G; Tainsh D
    PDA J Pharm Sci Technol; 2016; 70(2):163-76. PubMed ID: 26797977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioanalysis: challenges and solutions seminar.
    Roberts A
    Bioanalysis; 2011 Sep; 3(17):1905-6. PubMed ID: 21899500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 20. Compendial issues: WHO.
    Kopp-Kubel S
    J Parenter Sci Technol; 1992; 46(6):201-5. PubMed ID: 1474431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.